Global Tumor Blood Testing Market Research Report 2025(Status and Outlook)
Report Overview
Tumor blood testing, also known as liquid biopsy, is a non-invasive method of detecting cancer by analyzing tumor-derived materials such as circulating tumor cells (CTCs) or cell-free DNA (cfDNA) in the bloodstream. This innovative approach offers a less invasive alternative to traditional tissue biopsies, allowing for real-time monitoring of tumor progression, treatment response, and the emergence of resistance mutations. Tumor blood testing plays a crucial role in personalized medicine by providing valuable insights into the genetic makeup of tumors, enabling oncologists to tailor treatment strategies based on individual patient profiles. This technology has the potential to revolutionize cancer diagnosis and management by offering a more convenient and comprehensive approach to monitoring disease progression.
The market for tumor blood testing is experiencing rapid growth driven by several key factors. One of the primary market drivers is the increasing prevalence of cancer worldwide, leading to a growing demand for non-invasive diagnostic tools that can provide early detection and monitoring of the disease. Additionally, advancements in technology have significantly improved the sensitivity and accuracy of tumor blood testing methods, making them more reliable for clinical use. The rise of precision medicine and the growing emphasis on personalized treatment approaches have further fueled the adoption of liquid biopsy techniques in oncology practice. Moreover, the shift towards value-based healthcare models and the need for cost-effective diagnostic solutions are driving healthcare providers to incorporate tumor blood testing into routine clinical practice.
In addition to these market drivers, the expanding applications of tumor blood testing across various cancer types, including lung, breast, colorectal, and prostate cancers, are contributing to the market's growth. The ability of liquid biopsy to detect actionable mutations and genetic alterations that guide targeted therapy decisions is driving its adoption in oncology clinics worldwide. Furthermore, collaborations between biotechnology companies, academic institutions, and healthcare providers are fostering research and development efforts to enhance the performance and clinical utility of tumor blood testing technologies. As the field continues to evolve, with ongoing clinical trials and regulatory approvals, the market for tumor blood testing is poised for significant expansion in the coming years.
This report provides a deep insight into the global Tumor Blood Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tumor Blood Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tumor Blood Testing market in any manner.
Global Tumor Blood Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Guardant Health
Trovagene
Genomic Health
Roche
Bio-Techne
Pathway Genomics
Market Segmentation (by Type)
Blood Protein Testing
Tumor Marker Testing
Others
Market Segmentation (by Application)
Hospitals
Clinics
Ambulatory Surgical Centers
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tumor Blood Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Tumor blood testing, also known as liquid biopsy, is a non-invasive method of detecting cancer by analyzing tumor-derived materials such as circulating tumor cells (CTCs) or cell-free DNA (cfDNA) in the bloodstream. This innovative approach offers a less invasive alternative to traditional tissue biopsies, allowing for real-time monitoring of tumor progression, treatment response, and the emergence of resistance mutations. Tumor blood testing plays a crucial role in personalized medicine by providing valuable insights into the genetic makeup of tumors, enabling oncologists to tailor treatment strategies based on individual patient profiles. This technology has the potential to revolutionize cancer diagnosis and management by offering a more convenient and comprehensive approach to monitoring disease progression.
The market for tumor blood testing is experiencing rapid growth driven by several key factors. One of the primary market drivers is the increasing prevalence of cancer worldwide, leading to a growing demand for non-invasive diagnostic tools that can provide early detection and monitoring of the disease. Additionally, advancements in technology have significantly improved the sensitivity and accuracy of tumor blood testing methods, making them more reliable for clinical use. The rise of precision medicine and the growing emphasis on personalized treatment approaches have further fueled the adoption of liquid biopsy techniques in oncology practice. Moreover, the shift towards value-based healthcare models and the need for cost-effective diagnostic solutions are driving healthcare providers to incorporate tumor blood testing into routine clinical practice.
In addition to these market drivers, the expanding applications of tumor blood testing across various cancer types, including lung, breast, colorectal, and prostate cancers, are contributing to the market's growth. The ability of liquid biopsy to detect actionable mutations and genetic alterations that guide targeted therapy decisions is driving its adoption in oncology clinics worldwide. Furthermore, collaborations between biotechnology companies, academic institutions, and healthcare providers are fostering research and development efforts to enhance the performance and clinical utility of tumor blood testing technologies. As the field continues to evolve, with ongoing clinical trials and regulatory approvals, the market for tumor blood testing is poised for significant expansion in the coming years.
This report provides a deep insight into the global Tumor Blood Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tumor Blood Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tumor Blood Testing market in any manner.
Global Tumor Blood Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Guardant Health
Trovagene
Genomic Health
Roche
Bio-Techne
Pathway Genomics
Market Segmentation (by Type)
Blood Protein Testing
Tumor Marker Testing
Others
Market Segmentation (by Application)
Hospitals
Clinics
Ambulatory Surgical Centers
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Tumor Blood Testing Market
- Overview of the regional outlook of the Tumor Blood Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tumor Blood Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Tumor Blood Testing
1.2 Key Market Segments
1.2.1 Tumor Blood Testing Segment by Type
1.2.2 Tumor Blood Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUMOR BLOOD TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tumor Blood Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Tumor Blood Testing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUMOR BLOOD TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Tumor Blood Testing Product Life Cycle
3.3 Global Tumor Blood Testing Sales by Manufacturers (2020-2025)
3.4 Global Tumor Blood Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Tumor Blood Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Tumor Blood Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Tumor Blood Testing Sales Sites, Area Served, Product Type
3.8 Tumor Blood Testing Market Competitive Situation and Trends
3.8.1 Tumor Blood Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Tumor Blood Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TUMOR BLOOD TESTING INDUSTRY CHAIN ANALYSIS
4.1 Tumor Blood Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUMOR BLOOD TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Tumor Blood Testing Market Porter's Five Forces Analysis
5.7.1 Global Trade Frictions
5.7.2 Global Trade Frictions and Their Impacts to Tumor Blood Testing Market
5.8 ESG Ratings of Leading Companies
6 TUMOR BLOOD TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tumor Blood Testing Sales Market Share by Type (2020-2025)
6.3 Global Tumor Blood Testing Market Size Market Share by Type (2020-2025)
6.4 Global Tumor Blood Testing Price by Type (2020-2025)
7 TUMOR BLOOD TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tumor Blood Testing Market Sales by Application (2020-2025)
7.3 Global Tumor Blood Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Tumor Blood Testing Sales Growth Rate by Application (2020-2025)
8 TUMOR BLOOD TESTING MARKET SALES BY REGION
8.1 Global Tumor Blood Testing Sales by Region
8.1.1 Global Tumor Blood Testing Sales by Region
8.1.2 Global Tumor Blood Testing Sales Market Share by Region
8.2 Global Tumor Blood Testing Market Size by Region
8.2.1 Global Tumor Blood Testing Market Size by Region
8.2.2 Global Tumor Blood Testing Market Size Market Share by Region
8.3 North America
8.3.1 North America Tumor Blood Testing Sales by Country
8.3.2 North America Tumor Blood Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Tumor Blood Testing Sales by Country
8.4.2 Europe Tumor Blood Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Tumor Blood Testing Sales by Region
8.5.2 Asia Pacific Tumor Blood Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Tumor Blood Testing Sales by Country
8.6.2 South America Tumor Blood Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Tumor Blood Testing Sales by Region
8.7.2 Middle East and Africa Tumor Blood Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TUMOR BLOOD TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Tumor Blood Testing by Region(2020-2025)
9.2 Global Tumor Blood Testing Revenue Market Share by Region (2020-2025)
9.3 Global Tumor Blood Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Tumor Blood Testing Production
9.4.1 North America Tumor Blood Testing Production Growth Rate (2020-2025)
9.4.2 North America Tumor Blood Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Tumor Blood Testing Production
9.5.1 Europe Tumor Blood Testing Production Growth Rate (2020-2025)
9.5.2 Europe Tumor Blood Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Tumor Blood Testing Production (2020-2025)
9.6.1 Japan Tumor Blood Testing Production Growth Rate (2020-2025)
9.6.2 Japan Tumor Blood Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Tumor Blood Testing Production (2020-2025)
9.7.1 China Tumor Blood Testing Production Growth Rate (2020-2025)
9.7.2 China Tumor Blood Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Guardant Health
10.1.1 Guardant Health Basic Information
10.1.2 Guardant Health Tumor Blood Testing Product Overview
10.1.3 Guardant Health Tumor Blood Testing Product Market Performance
10.1.4 Guardant Health Business Overview
10.1.5 Guardant Health SWOT Analysis
10.1.6 Guardant Health Recent Developments
10.2 Trovagene
10.2.1 Trovagene Basic Information
10.2.2 Trovagene Tumor Blood Testing Product Overview
10.2.3 Trovagene Tumor Blood Testing Product Market Performance
10.2.4 Trovagene Business Overview
10.2.5 Trovagene SWOT Analysis
10.2.6 Trovagene Recent Developments
10.3 Genomic Health
10.3.1 Genomic Health Basic Information
10.3.2 Genomic Health Tumor Blood Testing Product Overview
10.3.3 Genomic Health Tumor Blood Testing Product Market Performance
10.3.4 Genomic Health Business Overview
10.3.5 Genomic Health SWOT Analysis
10.3.6 Genomic Health Recent Developments
10.4 Roche
10.4.1 Roche Basic Information
10.4.2 Roche Tumor Blood Testing Product Overview
10.4.3 Roche Tumor Blood Testing Product Market Performance
10.4.4 Roche Business Overview
10.4.5 Roche Recent Developments
10.5 Bio-Techne
10.5.1 Bio-Techne Basic Information
10.5.2 Bio-Techne Tumor Blood Testing Product Overview
10.5.3 Bio-Techne Tumor Blood Testing Product Market Performance
10.5.4 Bio-Techne Business Overview
10.5.5 Bio-Techne Recent Developments
10.6 Pathway Genomics
10.6.1 Pathway Genomics Basic Information
10.6.2 Pathway Genomics Tumor Blood Testing Product Overview
10.6.3 Pathway Genomics Tumor Blood Testing Product Market Performance
10.6.4 Pathway Genomics Business Overview
10.6.5 Pathway Genomics Recent Developments
11 TUMOR BLOOD TESTING MARKET FORECAST BY REGION
11.1 Global Tumor Blood Testing Market Size Forecast
11.2 Global Tumor Blood Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Tumor Blood Testing Market Size Forecast by Country
11.2.3 Asia Pacific Tumor Blood Testing Market Size Forecast by Region
11.2.4 South America Tumor Blood Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Tumor Blood Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Tumor Blood Testing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Tumor Blood Testing by Type (2026-2033)
12.1.2 Global Tumor Blood Testing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Tumor Blood Testing by Type (2026-2033)
12.2 Global Tumor Blood Testing Market Forecast by Application (2026-2033)
12.2.1 Global Tumor Blood Testing Sales (K Units) Forecast by Application
12.2.2 Global Tumor Blood Testing Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Tumor Blood Testing
1.2 Key Market Segments
1.2.1 Tumor Blood Testing Segment by Type
1.2.2 Tumor Blood Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUMOR BLOOD TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tumor Blood Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Tumor Blood Testing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUMOR BLOOD TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Tumor Blood Testing Product Life Cycle
3.3 Global Tumor Blood Testing Sales by Manufacturers (2020-2025)
3.4 Global Tumor Blood Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Tumor Blood Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Tumor Blood Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Tumor Blood Testing Sales Sites, Area Served, Product Type
3.8 Tumor Blood Testing Market Competitive Situation and Trends
3.8.1 Tumor Blood Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Tumor Blood Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TUMOR BLOOD TESTING INDUSTRY CHAIN ANALYSIS
4.1 Tumor Blood Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUMOR BLOOD TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Tumor Blood Testing Market Porter's Five Forces Analysis
5.7.1 Global Trade Frictions
5.7.2 Global Trade Frictions and Their Impacts to Tumor Blood Testing Market
5.8 ESG Ratings of Leading Companies
6 TUMOR BLOOD TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tumor Blood Testing Sales Market Share by Type (2020-2025)
6.3 Global Tumor Blood Testing Market Size Market Share by Type (2020-2025)
6.4 Global Tumor Blood Testing Price by Type (2020-2025)
7 TUMOR BLOOD TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tumor Blood Testing Market Sales by Application (2020-2025)
7.3 Global Tumor Blood Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Tumor Blood Testing Sales Growth Rate by Application (2020-2025)
8 TUMOR BLOOD TESTING MARKET SALES BY REGION
8.1 Global Tumor Blood Testing Sales by Region
8.1.1 Global Tumor Blood Testing Sales by Region
8.1.2 Global Tumor Blood Testing Sales Market Share by Region
8.2 Global Tumor Blood Testing Market Size by Region
8.2.1 Global Tumor Blood Testing Market Size by Region
8.2.2 Global Tumor Blood Testing Market Size Market Share by Region
8.3 North America
8.3.1 North America Tumor Blood Testing Sales by Country
8.3.2 North America Tumor Blood Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Tumor Blood Testing Sales by Country
8.4.2 Europe Tumor Blood Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Tumor Blood Testing Sales by Region
8.5.2 Asia Pacific Tumor Blood Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Tumor Blood Testing Sales by Country
8.6.2 South America Tumor Blood Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Tumor Blood Testing Sales by Region
8.7.2 Middle East and Africa Tumor Blood Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TUMOR BLOOD TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Tumor Blood Testing by Region(2020-2025)
9.2 Global Tumor Blood Testing Revenue Market Share by Region (2020-2025)
9.3 Global Tumor Blood Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Tumor Blood Testing Production
9.4.1 North America Tumor Blood Testing Production Growth Rate (2020-2025)
9.4.2 North America Tumor Blood Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Tumor Blood Testing Production
9.5.1 Europe Tumor Blood Testing Production Growth Rate (2020-2025)
9.5.2 Europe Tumor Blood Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Tumor Blood Testing Production (2020-2025)
9.6.1 Japan Tumor Blood Testing Production Growth Rate (2020-2025)
9.6.2 Japan Tumor Blood Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Tumor Blood Testing Production (2020-2025)
9.7.1 China Tumor Blood Testing Production Growth Rate (2020-2025)
9.7.2 China Tumor Blood Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Guardant Health
10.1.1 Guardant Health Basic Information
10.1.2 Guardant Health Tumor Blood Testing Product Overview
10.1.3 Guardant Health Tumor Blood Testing Product Market Performance
10.1.4 Guardant Health Business Overview
10.1.5 Guardant Health SWOT Analysis
10.1.6 Guardant Health Recent Developments
10.2 Trovagene
10.2.1 Trovagene Basic Information
10.2.2 Trovagene Tumor Blood Testing Product Overview
10.2.3 Trovagene Tumor Blood Testing Product Market Performance
10.2.4 Trovagene Business Overview
10.2.5 Trovagene SWOT Analysis
10.2.6 Trovagene Recent Developments
10.3 Genomic Health
10.3.1 Genomic Health Basic Information
10.3.2 Genomic Health Tumor Blood Testing Product Overview
10.3.3 Genomic Health Tumor Blood Testing Product Market Performance
10.3.4 Genomic Health Business Overview
10.3.5 Genomic Health SWOT Analysis
10.3.6 Genomic Health Recent Developments
10.4 Roche
10.4.1 Roche Basic Information
10.4.2 Roche Tumor Blood Testing Product Overview
10.4.3 Roche Tumor Blood Testing Product Market Performance
10.4.4 Roche Business Overview
10.4.5 Roche Recent Developments
10.5 Bio-Techne
10.5.1 Bio-Techne Basic Information
10.5.2 Bio-Techne Tumor Blood Testing Product Overview
10.5.3 Bio-Techne Tumor Blood Testing Product Market Performance
10.5.4 Bio-Techne Business Overview
10.5.5 Bio-Techne Recent Developments
10.6 Pathway Genomics
10.6.1 Pathway Genomics Basic Information
10.6.2 Pathway Genomics Tumor Blood Testing Product Overview
10.6.3 Pathway Genomics Tumor Blood Testing Product Market Performance
10.6.4 Pathway Genomics Business Overview
10.6.5 Pathway Genomics Recent Developments
11 TUMOR BLOOD TESTING MARKET FORECAST BY REGION
11.1 Global Tumor Blood Testing Market Size Forecast
11.2 Global Tumor Blood Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Tumor Blood Testing Market Size Forecast by Country
11.2.3 Asia Pacific Tumor Blood Testing Market Size Forecast by Region
11.2.4 South America Tumor Blood Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Tumor Blood Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Tumor Blood Testing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Tumor Blood Testing by Type (2026-2033)
12.1.2 Global Tumor Blood Testing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Tumor Blood Testing by Type (2026-2033)
12.2 Global Tumor Blood Testing Market Forecast by Application (2026-2033)
12.2.1 Global Tumor Blood Testing Sales (K Units) Forecast by Application
12.2.2 Global Tumor Blood Testing Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tumor Blood Testing Market Size Comparison by Region (M USD)
Table 5. Global Tumor Blood Testing Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Tumor Blood Testing Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Tumor Blood Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Tumor Blood Testing Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Blood Testing as of 2024)
Table 10. Global Market Tumor Blood Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Tumor Blood Testing Sales Sites and Area Served
Table 12. Manufacturers Tumor Blood Testing Product Type
Table 13. Global Tumor Blood Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Tumor Blood Testing Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Tumor Blood Testing Sales by Type (K Units)
Table 25. Global Tumor Blood Testing Market Size by Type (M USD)
Table 26. Global Tumor Blood Testing Sales (K Units) by Type (2020-2025)
Table 27. Global Tumor Blood Testing Sales Market Share by Type (2020-2025)
Table 28. Global Tumor Blood Testing Market Size (M USD) by Type (2020-2025)
Table 29. Global Tumor Blood Testing Market Size Share by Type (2020-2025)
Table 30. Global Tumor Blood Testing Price (USD/Unit) by Type (2020-2025)
Table 31. Global Tumor Blood Testing Sales (K Units) by Application
Table 32. Global Tumor Blood Testing Market Size by Application
Table 33. Global Tumor Blood Testing Sales by Application (2020-2025) & (K Units)
Table 34. Global Tumor Blood Testing Sales Market Share by Application (2020-2025)
Table 35. Global Tumor Blood Testing Market Size by Application (2020-2025) & (M USD)
Table 36. Global Tumor Blood Testing Market Share by Application (2020-2025)
Table 37. Global Tumor Blood Testing Sales Growth Rate by Application (2020-2025)
Table 38. Global Tumor Blood Testing Sales by Region (2020-2025) & (K Units)
Table 39. Global Tumor Blood Testing Sales Market Share by Region (2020-2025)
Table 40. Global Tumor Blood Testing Market Size by Region (2020-2025) & (M USD)
Table 41. Global Tumor Blood Testing Market Size Market Share by Region (2020-2025)
Table 42. North America Tumor Blood Testing Sales by Country (2020-2025) & (K Units)
Table 43. North America Tumor Blood Testing Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Tumor Blood Testing Sales by Country (2020-2025) & (K Units)
Table 45. Europe Tumor Blood Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Tumor Blood Testing Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Tumor Blood Testing Market Size by Region (2020-2025) & (M USD)
Table 48. South America Tumor Blood Testing Sales by Country (2020-2025) & (K Units)
Table 49. South America Tumor Blood Testing Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Tumor Blood Testing Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Tumor Blood Testing Market Size by Region (2020-2025) & (M USD)
Table 52. Global Tumor Blood Testing Production (K Units) by Region(2020-2025)
Table 53. Global Tumor Blood Testing Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Tumor Blood Testing Revenue Market Share by Region (2020-2025)
Table 55. Global Tumor Blood Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Tumor Blood Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Tumor Blood Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Tumor Blood Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Tumor Blood Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Guardant Health Basic Information
Table 61. Guardant Health Tumor Blood Testing Product Overview
Table 62. Guardant Health Tumor Blood Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Guardant Health Business Overview
Table 64. Guardant Health SWOT Analysis
Table 65. Guardant Health Recent Developments
Table 66. Trovagene Basic Information
Table 67. Trovagene Tumor Blood Testing Product Overview
Table 68. Trovagene Tumor Blood Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Trovagene Business Overview
Table 70. Trovagene SWOT Analysis
Table 71. Trovagene Recent Developments
Table 72. Genomic Health Basic Information
Table 73. Genomic Health Tumor Blood Testing Product Overview
Table 74. Genomic Health Tumor Blood Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Genomic Health Business Overview
Table 76. Genomic Health SWOT Analysis
Table 77. Genomic Health Recent Developments
Table 78. Roche Basic Information
Table 79. Roche Tumor Blood Testing Product Overview
Table 80. Roche Tumor Blood Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Roche Business Overview
Table 82. Roche Recent Developments
Table 83. Bio-Techne Basic Information
Table 84. Bio-Techne Tumor Blood Testing Product Overview
Table 85. Bio-Techne Tumor Blood Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Bio-Techne Business Overview
Table 87. Bio-Techne Recent Developments
Table 88. Pathway Genomics Basic Information
Table 89. Pathway Genomics Tumor Blood Testing Product Overview
Table 90. Pathway Genomics Tumor Blood Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Pathway Genomics Business Overview
Table 92. Pathway Genomics Recent Developments
Table 93. Global Tumor Blood Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 94. Global Tumor Blood Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 95. North America Tumor Blood Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 96. North America Tumor Blood Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 97. Europe Tumor Blood Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 98. Europe Tumor Blood Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 99. Asia Pacific Tumor Blood Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 100. Asia Pacific Tumor Blood Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 101. South America Tumor Blood Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 102. South America Tumor Blood Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 103. Middle East and Africa Tumor Blood Testing Sales Forecast by Country (2026-2033) & (Units)
Table 104. Middle East and Africa Tumor Blood Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 105. Global Tumor Blood Testing Sales Forecast by Type (2026-2033) & (K Units)
Table 106. Global Tumor Blood Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 107. Global Tumor Blood Testing Price Forecast by Type (2026-2033) & (USD/Unit)
Table 108. Global Tumor Blood Testing Sales (K Units) Forecast by Application (2026-2033)
Table 109. Global Tumor Blood Testing Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tumor Blood Testing Market Size Comparison by Region (M USD)
Table 5. Global Tumor Blood Testing Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Tumor Blood Testing Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Tumor Blood Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Tumor Blood Testing Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Blood Testing as of 2024)
Table 10. Global Market Tumor Blood Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Tumor Blood Testing Sales Sites and Area Served
Table 12. Manufacturers Tumor Blood Testing Product Type
Table 13. Global Tumor Blood Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Tumor Blood Testing Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Tumor Blood Testing Sales by Type (K Units)
Table 25. Global Tumor Blood Testing Market Size by Type (M USD)
Table 26. Global Tumor Blood Testing Sales (K Units) by Type (2020-2025)
Table 27. Global Tumor Blood Testing Sales Market Share by Type (2020-2025)
Table 28. Global Tumor Blood Testing Market Size (M USD) by Type (2020-2025)
Table 29. Global Tumor Blood Testing Market Size Share by Type (2020-2025)
Table 30. Global Tumor Blood Testing Price (USD/Unit) by Type (2020-2025)
Table 31. Global Tumor Blood Testing Sales (K Units) by Application
Table 32. Global Tumor Blood Testing Market Size by Application
Table 33. Global Tumor Blood Testing Sales by Application (2020-2025) & (K Units)
Table 34. Global Tumor Blood Testing Sales Market Share by Application (2020-2025)
Table 35. Global Tumor Blood Testing Market Size by Application (2020-2025) & (M USD)
Table 36. Global Tumor Blood Testing Market Share by Application (2020-2025)
Table 37. Global Tumor Blood Testing Sales Growth Rate by Application (2020-2025)
Table 38. Global Tumor Blood Testing Sales by Region (2020-2025) & (K Units)
Table 39. Global Tumor Blood Testing Sales Market Share by Region (2020-2025)
Table 40. Global Tumor Blood Testing Market Size by Region (2020-2025) & (M USD)
Table 41. Global Tumor Blood Testing Market Size Market Share by Region (2020-2025)
Table 42. North America Tumor Blood Testing Sales by Country (2020-2025) & (K Units)
Table 43. North America Tumor Blood Testing Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Tumor Blood Testing Sales by Country (2020-2025) & (K Units)
Table 45. Europe Tumor Blood Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Tumor Blood Testing Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Tumor Blood Testing Market Size by Region (2020-2025) & (M USD)
Table 48. South America Tumor Blood Testing Sales by Country (2020-2025) & (K Units)
Table 49. South America Tumor Blood Testing Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Tumor Blood Testing Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Tumor Blood Testing Market Size by Region (2020-2025) & (M USD)
Table 52. Global Tumor Blood Testing Production (K Units) by Region(2020-2025)
Table 53. Global Tumor Blood Testing Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Tumor Blood Testing Revenue Market Share by Region (2020-2025)
Table 55. Global Tumor Blood Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Tumor Blood Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Tumor Blood Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Tumor Blood Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Tumor Blood Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Guardant Health Basic Information
Table 61. Guardant Health Tumor Blood Testing Product Overview
Table 62. Guardant Health Tumor Blood Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Guardant Health Business Overview
Table 64. Guardant Health SWOT Analysis
Table 65. Guardant Health Recent Developments
Table 66. Trovagene Basic Information
Table 67. Trovagene Tumor Blood Testing Product Overview
Table 68. Trovagene Tumor Blood Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Trovagene Business Overview
Table 70. Trovagene SWOT Analysis
Table 71. Trovagene Recent Developments
Table 72. Genomic Health Basic Information
Table 73. Genomic Health Tumor Blood Testing Product Overview
Table 74. Genomic Health Tumor Blood Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Genomic Health Business Overview
Table 76. Genomic Health SWOT Analysis
Table 77. Genomic Health Recent Developments
Table 78. Roche Basic Information
Table 79. Roche Tumor Blood Testing Product Overview
Table 80. Roche Tumor Blood Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Roche Business Overview
Table 82. Roche Recent Developments
Table 83. Bio-Techne Basic Information
Table 84. Bio-Techne Tumor Blood Testing Product Overview
Table 85. Bio-Techne Tumor Blood Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Bio-Techne Business Overview
Table 87. Bio-Techne Recent Developments
Table 88. Pathway Genomics Basic Information
Table 89. Pathway Genomics Tumor Blood Testing Product Overview
Table 90. Pathway Genomics Tumor Blood Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Pathway Genomics Business Overview
Table 92. Pathway Genomics Recent Developments
Table 93. Global Tumor Blood Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 94. Global Tumor Blood Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 95. North America Tumor Blood Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 96. North America Tumor Blood Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 97. Europe Tumor Blood Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 98. Europe Tumor Blood Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 99. Asia Pacific Tumor Blood Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 100. Asia Pacific Tumor Blood Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 101. South America Tumor Blood Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 102. South America Tumor Blood Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 103. Middle East and Africa Tumor Blood Testing Sales Forecast by Country (2026-2033) & (Units)
Table 104. Middle East and Africa Tumor Blood Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 105. Global Tumor Blood Testing Sales Forecast by Type (2026-2033) & (K Units)
Table 106. Global Tumor Blood Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 107. Global Tumor Blood Testing Price Forecast by Type (2026-2033) & (USD/Unit)
Table 108. Global Tumor Blood Testing Sales (K Units) Forecast by Application (2026-2033)
Table 109. Global Tumor Blood Testing Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Tumor Blood Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tumor Blood Testing Market Size (M USD), 2024-2033
Figure 5. Global Tumor Blood Testing Market Size (M USD) (2020-2033)
Figure 6. Global Tumor Blood Testing Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tumor Blood Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Tumor Blood Testing Product Life Cycle
Figure 13. Tumor Blood Testing Sales Share by Manufacturers in 2024
Figure 14. Global Tumor Blood Testing Revenue Share by Manufacturers in 2024
Figure 15. Tumor Blood Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Tumor Blood Testing Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Tumor Blood Testing Revenue in 2024
Figure 18. Industry Chain Map of Tumor Blood Testing
Figure 19. Global Tumor Blood Testing Market PESTE Analysis
Figure 20. Global Tumor Blood Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Tumor Blood Testing Market Share by Type
Figure 27. Sales Market Share of Tumor Blood Testing by Type (2020-2025)
Figure 28. Sales Market Share of Tumor Blood Testing by Type in 2024
Figure 29. Market Size Share of Tumor Blood Testing by Type (2020-2025)
Figure 30. Market Size Share of Tumor Blood Testing by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Tumor Blood Testing Market Share by Application
Figure 33. Global Tumor Blood Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Tumor Blood Testing Sales Market Share by Application in 2024
Figure 35. Global Tumor Blood Testing Market Share by Application (2020-2025)
Figure 36. Global Tumor Blood Testing Market Share by Application in 2024
Figure 37. Global Tumor Blood Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Tumor Blood Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Tumor Blood Testing Market Size Market Share by Region (2020-2025)
Figure 40. North America Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Tumor Blood Testing Sales Market Share by Country in 2024
Figure 43. North America Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Tumor Blood Testing Market Size Market Share by Country in 2024
Figure 45. U.S. Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Tumor Blood Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Tumor Blood Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Tumor Blood Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Tumor Blood Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Tumor Blood Testing Sales Market Share by Country in 2024
Figure 53. Europe Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Tumor Blood Testing Market Size Market Share by Country in 2024
Figure 55. Germany Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Tumor Blood Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Tumor Blood Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Tumor Blood Testing Market Size Market Share by Region in 2024
Figure 68. China Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Tumor Blood Testing Sales and Growth Rate (K Units)
Figure 79. South America Tumor Blood Testing Sales Market Share by Country in 2024
Figure 80. South America Tumor Blood Testing Market Size and Growth Rate (M USD)
Figure 81. South America Tumor Blood Testing Market Size Market Share by Country in 2024
Figure 82. Brazil Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Tumor Blood Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Tumor Blood Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Tumor Blood Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Tumor Blood Testing Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Tumor Blood Testing Production Market Share by Region (2020-2025)
Figure 103. North America Tumor Blood Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Tumor Blood Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Tumor Blood Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Tumor Blood Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Tumor Blood Testing Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Tumor Blood Testing Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Tumor Blood Testing Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Tumor Blood Testing Market Share Forecast by Type (2026-2033)
Figure 111. Global Tumor Blood Testing Sales Forecast by Application (2026-2033)
Figure 112. Global Tumor Blood Testing Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Tumor Blood Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tumor Blood Testing Market Size (M USD), 2024-2033
Figure 5. Global Tumor Blood Testing Market Size (M USD) (2020-2033)
Figure 6. Global Tumor Blood Testing Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tumor Blood Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Tumor Blood Testing Product Life Cycle
Figure 13. Tumor Blood Testing Sales Share by Manufacturers in 2024
Figure 14. Global Tumor Blood Testing Revenue Share by Manufacturers in 2024
Figure 15. Tumor Blood Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Tumor Blood Testing Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Tumor Blood Testing Revenue in 2024
Figure 18. Industry Chain Map of Tumor Blood Testing
Figure 19. Global Tumor Blood Testing Market PESTE Analysis
Figure 20. Global Tumor Blood Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Tumor Blood Testing Market Share by Type
Figure 27. Sales Market Share of Tumor Blood Testing by Type (2020-2025)
Figure 28. Sales Market Share of Tumor Blood Testing by Type in 2024
Figure 29. Market Size Share of Tumor Blood Testing by Type (2020-2025)
Figure 30. Market Size Share of Tumor Blood Testing by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Tumor Blood Testing Market Share by Application
Figure 33. Global Tumor Blood Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Tumor Blood Testing Sales Market Share by Application in 2024
Figure 35. Global Tumor Blood Testing Market Share by Application (2020-2025)
Figure 36. Global Tumor Blood Testing Market Share by Application in 2024
Figure 37. Global Tumor Blood Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Tumor Blood Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Tumor Blood Testing Market Size Market Share by Region (2020-2025)
Figure 40. North America Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Tumor Blood Testing Sales Market Share by Country in 2024
Figure 43. North America Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Tumor Blood Testing Market Size Market Share by Country in 2024
Figure 45. U.S. Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Tumor Blood Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Tumor Blood Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Tumor Blood Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Tumor Blood Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Tumor Blood Testing Sales Market Share by Country in 2024
Figure 53. Europe Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Tumor Blood Testing Market Size Market Share by Country in 2024
Figure 55. Germany Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Tumor Blood Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Tumor Blood Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Tumor Blood Testing Market Size Market Share by Region in 2024
Figure 68. China Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Tumor Blood Testing Sales and Growth Rate (K Units)
Figure 79. South America Tumor Blood Testing Sales Market Share by Country in 2024
Figure 80. South America Tumor Blood Testing Market Size and Growth Rate (M USD)
Figure 81. South America Tumor Blood Testing Market Size Market Share by Country in 2024
Figure 82. Brazil Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Tumor Blood Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Tumor Blood Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Tumor Blood Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Tumor Blood Testing Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Tumor Blood Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Tumor Blood Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Tumor Blood Testing Production Market Share by Region (2020-2025)
Figure 103. North America Tumor Blood Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Tumor Blood Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Tumor Blood Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Tumor Blood Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Tumor Blood Testing Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Tumor Blood Testing Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Tumor Blood Testing Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Tumor Blood Testing Market Share Forecast by Type (2026-2033)
Figure 111. Global Tumor Blood Testing Sales Forecast by Application (2026-2033)
Figure 112. Global Tumor Blood Testing Market Share Forecast by Application (2026-2033)
